Revolutionizing Anticoagulation for Thrombosis: Micro Insights on Next-Generation Factor XI/XIa Inhibitor Approaches

Revolutionizing Anticoagulation for Thrombosis: Micro Insights on Next-Generation Factor XI/XIa Inhibitor Approaches

The goal of this activity is for learners to be better able to identify gaps in current management of thromboembolic disease as it relates to thromboembolic protection with anticoagulation and evaluate future strategies for thrombosis prevention with factor XI/XIa inhibitors across thromboembolic associated conditions including AF and VTE.

  • Provider:Medscape, LLC
  • Activity Link: https://www.medscape.org/viewarticle/1001634
  • Start Date: 2024-09-25 05:00:00
  • End Date: 2024-09-25 05:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
    Pharmacy: 0.75 hours
  • Commercial Support: Source: Anthos Therapeutics - Amount: 154881.0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.